Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2025 Filed Jul 2, 2025 20:29 UTC |
Jafry Syed A.Director
|
GrantPhantom Stock Units · Derivative | 178.355 | $0.00 Strike: $91.11 | $0.00 |
DisclosureSEC source: 0001062993-25-012457 · form4.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,153.79 Underlying: Common Stock · 178.355 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:28 UTC |
Kolli SreelakshmiDirector
|
GrantPhantom Stock Units · Derivative | 171.496 | $0.00 Strike: $91.11 | $0.00 |
DisclosureSEC source: 0001062993-25-012455 · form4.xml · derivative · entry 1 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,221.199 Underlying: Common Stock · 171.496 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:26 UTC |
Kurdikar DevdattDirector
|
GrantPhantom Stock Units · Derivative | 150.916 | $0.00 Strike: $91.11 | $0.00 |
DisclosureSEC source: 0001062993-25-012452 · form4.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,470.296 Underlying: Common Stock · 150.916 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:06 UTC |
Yi SangGroup President, Asia Pacific
|
SaleCommon Stock | 800 | $92.51 | $74,011.20 |
DisclosureSEC source: 0001062993-25-011810 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,624 Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:39 UTC |
Yi SangGroup President, Asia Pacific
|
SaleCommon Stock | 1,000 | $95.00 | $95,000.00 |
DisclosureSEC source: 0001062993-25-011674 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,424 Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 20:38 UTC |
Stellato Paul AVP, Controller & CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 626 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010833 · form4.xml · derivative · entry 3 Stellato Paul A · CIK 0001714585 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on each of June 1, 2023, June 1, 2024 and June 1, 2025. F3 · derivative.expiration_date: One-third of the RSUs vested on each of June 1, 2023, June 1, 2024 and June 1, 2025. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 20:38 UTC |
Stellato Paul AVP, Controller & CAO
|
Tax withholdingCommon Stock | 197 | $92.24 | $18,171.28 |
DisclosureSEC source: 0001062993-25-010833 · form4.xml · nonDerivative · entry 2 Stellato Paul A · CIK 0001714585 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,772 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 20:38 UTC |
Stellato Paul AVP, Controller & CAO
|
Exercise / conversionCommon Stock | 626 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010833 · form4.xml · nonDerivative · entry 1 Stellato Paul A · CIK 0001714585 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 23:21 UTC |
Farrell Michael J.Director
|
GrantRestricted Stock Units · Derivative | 1,404.798 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010736 · form4.xml · derivative · entry 2 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,239.726 Underlying: Common Stock · 1,404.798 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 23:21 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 810.46 | $0.00 Strike: $92.54 | $0.00 |
DisclosureSEC source: 0001062993-25-010736 · form4.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,427.538 Underlying: Common Stock · 810.46 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 36.578 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 23:19 UTC |
Hilado Maria TeresaDirector
|
GrantRestricted Stock Units · Derivative | 1,404.798 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010734 · form4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,580.726 Underlying: Common Stock · 1,404.798 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 23:19 UTC |
Hilado Maria TeresaDirector
|
GrantPhantom Stock Units · Derivative | 810.46 | $0.00 Strike: $92.54 | $0.00 |
DisclosureSEC source: 0001062993-25-010734 · form4.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,134.921 Underlying: Common Stock · 810.46 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: These units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 21.839 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:48 UTC |
Kurdikar DevdattDirector
|
GrantRestricted Stock Units · Derivative | 1,404.798 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010731 · form4.xml · derivative · entry 2 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,404.798 Underlying: Common Stock · 1,404.798 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:48 UTC |
Kurdikar DevdattDirector
|
GrantPhantom Stock Units · Derivative | 810.46 | $0.00 Strike: $92.54 | $0.00 |
DisclosureSEC source: 0001062993-25-010731 · form4.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,319.38 Underlying: Common Stock · 810.46 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 1.192 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:47 UTC |
Kolli SreelakshmiDirector
|
GrantRestricted Stock Units · Derivative | 1,404.798 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010729 · form4.xml · derivative · entry 2 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,357.726 Underlying: Common Stock · 1,404.798 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:47 UTC |
Kolli SreelakshmiDirector
|
GrantPhantom Stock Units · Derivative | 810.46 | $0.00 Strike: $92.54 | $0.00 |
DisclosureSEC source: 0001062993-25-010729 · form4.xml · derivative · entry 1 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,049.703 Underlying: Common Stock · 810.46 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 9.929 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:47 UTC |
Jafry Syed A.Director
|
GrantRestricted Stock Units · Derivative | 1,404.798 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010728 · form4.xml · derivative · entry 2 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,580.726 Underlying: Common Stock · 1,404.798 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:47 UTC |
Jafry Syed A.Director
|
GrantPhantom Stock Units · Derivative | 810.46 | $0.00 Strike: $92.54 | $0.00 |
DisclosureSEC source: 0001062993-25-010728 · form4.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,975.435 Underlying: Common Stock · 810.46 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 14.439 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:46 UTC |
HIGGINS ARTHUR JDirector
|
GrantRestricted Stock Units · Derivative | 1,404.798 | $5.00 | $7,023.99 |
DisclosureSEC source: 0001062993-25-010725 · form4.xml · derivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,864.726 Underlying: Common Stock · 1,404.798 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:46 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 810.46 | $0.00 Strike: $92.54 | $0.00 |
DisclosureSEC source: 0001062993-25-010725 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,904.384 Underlying: Common Stock · 810.46 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 79.853 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:44 UTC |
HAGEMANN ROBERTDirector
|
GrantRestricted Stock Units · Derivative | 1,404.798 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010721 · form4.xml · derivative · entry 2 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,409.726 Underlying: Common Stock · 1,404.798 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:44 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 810.46 | $0.00 Strike: $92.54 | $0.00 |
DisclosureSEC source: 0001062993-25-010721 · form4.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,477.633 Underlying: Common Stock · 810.46 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: These units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 69.485 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:43 UTC |
BERNARD BETSY JDirector
|
GrantRestricted Stock Units · Derivative | 1,404.798 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010718 · form4.xml · derivative · entry 2 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,988.726 Underlying: Common Stock · 1,404.798 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:43 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 810.46 | $0.00 Strike: $92.54 | $0.00 |
DisclosureSEC source: 0001062993-25-010718 · form4.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,485.689 Underlying: Common Stock · 810.46 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 46.082 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:43 UTC |
Shapiro LouisDirector
|
GrantRestricted Stock Units · Derivative | 1,404.798 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-010717 · form4.xml · derivative · entry 2 Shapiro Louis · CIK 0001999146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,473.789 Underlying: Common Stock · 1,404.798 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 22:43 UTC |
Shapiro LouisDirector
|
GrantPhantom Stock Units · Derivative | 810.46 | $0.00 Strike: $92.54 | $0.00 |
DisclosureSEC source: 0001062993-25-010717 · form4.xml · derivative · entry 1 Shapiro Louis · CIK 0001999146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,046.114 Underlying: Common Stock · 810.46 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 2.894 phantom stock units accrued on April 30, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 21:06 UTC |
Noor JehanzebSee remarks below.
|
GrantRestricted Stock Units · Derivative | 19,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-006996 · form4.xml · derivative · entry 1 Noor Jehanzeb · CIK 0002059755 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,875 Underlying: Common Stock · 19,875 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing April 1, 2026. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing April 1, 2026. Read SEC document |
| March 31, 2025 Filed Apr 3, 2025 00:40 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 288.863 | $0.00 Strike: $112.51 | $0.00 |
DisclosureSEC source: 0001062993-25-006908 · form4.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,580.5 Underlying: Common Stock · 288.863 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 32.604 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:11 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 533.286 | $0.00 Strike: $112.51 | $0.00 |
DisclosureSEC source: 0001062993-25-006824 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,937.582 Underlying: Common Stock · 533.286 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 45.338 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:10 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 299.974 | $0.00 Strike: $112.51 | $0.00 |
DisclosureSEC source: 0001062993-25-006822 · form4.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,597.688 Underlying: Common Stock · 299.974 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 63.054 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:09 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 244.423 | $0.00 Strike: $112.51 | $0.00 |
DisclosureSEC source: 0001062993-25-006821 · form4.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,014.071 Underlying: Common Stock · 244.423 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 72.913 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:07 UTC |
Kolli SreelakshmiDirector
|
GrantPhantom Stock Units · Derivative | 138.876 | $0.00 Strike: $112.51 | $0.00 |
DisclosureSEC source: 0001062993-25-006819 · form4.xml · derivative · entry 1 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,229.314 Underlying: Common Stock · 138.876 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 8.579 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:07 UTC |
Hilado Maria TeresaDirector
|
GrantPhantom Stock Units · Derivative | 244.423 | $0.00 Strike: $112.51 | $0.00 |
DisclosureSEC source: 0001062993-25-006820 · form4.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,302.622 Underlying: Common Stock · 244.423 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 19.144 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:04 UTC |
Shapiro LouisDirector
|
GrantPhantom Stock Units · Derivative | 122.211 | $0.00 Strike: $112.51 | $0.00 |
DisclosureSEC source: 0001062993-25-006816 · form4.xml · derivative · entry 1 Shapiro Louis · CIK 0001999146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,232.76 Underlying: Common Stock · 122.211 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 2.133 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:03 UTC |
Kurdikar DevdattDirector
|
GrantPhantom Stock Units · Derivative | 122.211 | $0.00 Strike: $112.51 | $0.00 |
DisclosureSEC source: 0001062993-25-006815 · form4.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 507.728 Underlying: Common Stock · 122.211 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 0.556 phantom stock units accrued January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:53 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004989 · form4.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,094 Underlying: Common Stock · 2,094 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: 2,094 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026. F3 · derivative.expiration_date: 2,094 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:53 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Tax withholdingCommon Stock | 824 | $104.86 | $86,404.64 |
DisclosureSEC source: 0001062993-25-004989 · form4.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,038 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:53 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionCommon Stock | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004989 · form4.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:39 UTC |
Bezjak MarkPresident, Americas
|
Exercise / conversionRestricted Stock Units · Derivative | 1,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004977 · form4.xml · derivative · entry 3 Bezjak Mark · CIK 0002004536 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,621 Underlying: Common Stock · 1,621 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: 1,621 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026. F3 · derivative.expiration_date: 1,621 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:39 UTC |
Bezjak MarkPresident, Americas
|
Tax withholdingCommon Stock | 638 | $104.86 | $66,900.68 |
DisclosureSEC source: 0001062993-25-004977 · form4.xml · nonDerivative · entry 2 Bezjak Mark · CIK 0002004536 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,134 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:39 UTC |
Bezjak MarkPresident, Americas
|
Exercise / conversionCommon Stock | 1,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004977 · form4.xml · nonDerivative · entry 1 Bezjak Mark · CIK 0002004536 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:38 UTC |
Stellato Paul AVP, Controller & CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004975 · form4.xml · derivative · entry 3 Stellato Paul A · CIK 0001714585 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 607 Underlying: Common Stock · 608 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: 608 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 F3 · derivative.expiration_date: 608 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:38 UTC |
Stellato Paul AVP, Controller & CAO
|
Tax withholdingCommon Stock | 191 | $104.86 | $20,028.26 |
DisclosureSEC source: 0001062993-25-004975 · form4.xml · nonDerivative · entry 2 Stellato Paul A · CIK 0001714585 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,343 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:38 UTC |
Stellato Paul AVP, Controller & CAO
|
Exercise / conversionCommon Stock | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004975 · form4.xml · nonDerivative · entry 1 Stellato Paul A · CIK 0001714585 · VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:37 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004974 · form4.xml · derivative · entry 4 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,756 Underlying: Common Stock · 1,757 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: 1,757 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 F3 · derivative.expiration_date: 1,757 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:37 UTC |
Winkler LoriSVP and CHRO
|
Tax withholdingCommon Stock | 692 | $104.86 | $72,563.12 |
DisclosureSEC source: 0001062993-25-004974 · form4.xml · nonDerivative · entry 3 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,833 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:37 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionCommon Stock | 1,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004974 · form4.xml · nonDerivative · entry 2 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:36 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionRestricted Stock Units · Derivative | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004973 · form4.xml · derivative · entry 3 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,161 Underlying: Common Stock · 2,162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: 2,162 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 F3 · derivative.expiration_date: 2,162 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:36 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Tax withholdingCommon Stock | 569 | $104.86 | $59,665.34 |
DisclosureSEC source: 0001062993-25-004973 · form4.xml · nonDerivative · entry 2 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,534 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:36 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionCommon Stock | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004973 · form4.xml · nonDerivative · entry 1 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.